Human Apolipoprotein H Antibody (IgG) ELISA Kit (Sandwich ELISA)
Catalog Number: LS-F67372-1
1 plate / $591.00
Reactivity: Human
Detection Method Colorimetric
Format: 96-Well Strip Plate
DNMT3A Antibody (CenterR478) western blot of HL-60 cell line lysates (35 ug/lane). The DNMT3A antibody detected the DNMT3A protein (arrow).
DNMT3A Antibody (aa457-486)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Immunohistochemistry (general), Western Blot |
| Reactivity: | Human |
| Format: | Liquid |
$401.00each
Catalog Number: LS-C167495-400
Catalog Number: LS-C167495
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- DNMT3A antibody LS-C167495 is an unconjugated rabbit polyclonal antibody to human DNMT3A (aa457-486). Validated for WB. Cited in 1 publication.
- Application
- IHC, WB
- Reactivity
- Hu
- Predicted Reactivity
- Chicken, Mouse, Rat
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- DNA MTase HsaIIIA | DNMT3A2 | DNA methyltransferase HsaIIIA | DNMT3A | M.HsaIIIA
- Recommended Dilution: WB
- 1:1000
- UniProt Number
- Q9Y6K1
- NCBI GenBank
- NM_022552 | NP_072046.2
- SwissProt
- Q9Y6K1
Target
- Target
- Human DNMT3A
- Antigen Species
- Human
- Epitope
- This Dnmt3a antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 457-486 amino acids from the Central region of human Dnmt3a.
- Gene Name
- DNMT3A
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
Immunogen
- Immunogen Type
- Peptide
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.09% Sodium Azide
- Volume
- 400 Microliter
- Preservative
- Yes
- Purification Method
- Protein A Affinity
Storage & Handling
- Storage Conditions
- Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.
- Recommended Storage Buffer
- PBS
Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma. Lee HG, Kim H, Son T, Jeong Y, Kim SU, Dong SM, Park YN, Lee JD, Lee JM, Park JH. Oncotarget. 2016 July;7:41798-41810. PubMed: 27260001 PMC: PMC5173097
